Other
Pictorial Essay
November 2002

Positron Emission Tomography and PET CT of the Head and Neck: FDG Uptake in Normal Anatomy, in Benign Lesions, and in Changes Resulting from Treatment

During recent years, positron emission tomography (PET) with FDG has become an established imaging method for the evaluation of patients with head and neck cancer [1,2,3,4]. However, the anatomic information acquired with PET is limited, and correlation with structural imaging such as CT is important. Recently, combined in-line PET CT devices that allow the coregistration of functional and anatomic information have been introduced into clinical practice. On combined PET CT cameras, conventional transmission scanning using the built-in germanium-68 sources can be replaced by CT [5]. This capability can influence the quality of coregistered PET CT images and of attenuation-corrected PET images. We present the spectrum of PET and PET CT imaging of the head and neck for normal anatomy, benign lesions, and changes resulting from treatment.

Technical Aspects of Imaging

PET images have been reconstructed using filtered back-projection, but iterative reconstruction algorithms are used increasingly for routine clinical imaging. Attenuation correction is done with a transmission scan; it requires perfect alignment of the patient during emission and transmission scanning. If the patient moves between the two scans, attenuation correction will not be accurate, and artifacts will result. Such movement artifacts also occur in combined PET CT imaging when a CT image is used for attenuation correction. A lateral movement of the patient's head will result in an asymmetric appearance of the PET image with one side of the head appearing slightly darker than the other side (Fig. 1A,1B,1C). This discrepancy does not necessarily disturb final image interpretation because malignant lesions usually have intense FDG uptake. Larger head movements may render interpretation of attenuation-corrected images impossible; therefore, the emission scans that are not attenuation-corrected should also be evaluated.
Fig. 1A. 53-year-old man with hypopharyngeal carcinoma. Transverse emission image (reconstructed using filtered back-projection) shows no evidence of disease at oral cavity level.
Fig. 1B. 53-year-old man with hypopharyngeal carcinoma. CT image corresponding to A obtained for attenuation correction and image coregistration shows artifacts caused by dental metalwork.
Fig. 1C. 53-year-old man with hypopharyngeal carcinoma. Attenuation-corrected positron emission tomography image (reconstructed using iterative ordered subset expectation maximization algorithm) at same level as B. Slight movement of patient's head between emission and transmission scanning caused asymmetric appearance and slightly darker left side of head (arrows).

Dental Metalwork

Metal used for dental work will produce a defect in the emission image as a result of excessive photon absorption by the metal (Fig. 2A,2B,2C). In attenuation-corrected images, nonremovable metal dentures, bridgework, and other such items can cause artifacts that mimic FDG uptake (Fig. 2A,2B,2C). These artifacts may look like small lesions in the periodontal space. Artifacts arise in both conventional and CT-based attenuation-correction methods because material with high density can create data inconsistencies in the attenuation map [6]. In patients with nonremovable metal dentures, emission images can be useful in the interpretation of the oral cavity (Fig. 2A,2B,2C). If attenuation correction is performed by means of the CT scan, stripe artifacts on the CT image can be visible on the final attenuation-corrected PET image (Fig. 3A,3B).
Fig. 2A. 57-year-old woman with bronchogenic carcinoma. Transverse positron emission tomography (PET) emission image shows normal appearance of oral cavity. Dental metalwork generates white spots (arrows) where information is lacking.
Fig. 2B. 57-year-old woman with bronchogenic carcinoma. Same PET image as A with attenuation correction shows artifacts arising adjacent to metal (long arrows) that mimic increased FDG uptake. Moderately increased uptake (short arrow) due to inflammation is visible in right tonsil.
Fig. 2C. 57-year-old woman with bronchogenic carcinoma. Coregistered PET CT image corresponding to B shows artifacts that render image interpretation of oral cavity difficult.
Fig. 3A. 72-year-old man with bronchogenic carcinoma. Transverse coregistered positron emission tomography (PET) CT image illustrates beam-hardening stripe artifacts (arrows) from CT image that were caused by dental metalwork.
Fig. 3B. 72-year-old man with bronchogenic carcinoma. PET image corresponding to A shows that such artifacts (arrows) can be introduced into final PET image if CT data are used for attenuation correction.

Normal Tissues of the Head and Neck

Low to moderate FDG uptake occurs in the tonsils and at the base of the tongue because of the physiologic accumulation in the lymphatic tissue in Waldeyer's ring (Fig. 4A,4B). Variable but usually low FDG uptake is visible in the salivary glands, which physiologically secrete low amounts of glucose (Figs. 4A,4B and 5A,5B). A moderately increased FDG uptake can be seen in the anterior part of the floor of the mouth corresponding to the genioglossus muscle, which prevents the tongue from falling back in supine patients (Fig. 6A,6B). Muscular uptake can be seen in the masticator muscles (Fig. 7A,7B,7C), the tip of the tongue, and muscles of the face, neck, and larynx in nervous patients and in patients who speak during the FDG uptake phase (Fig. 8). In nervous patients, muscular uptake can be avoided by using medication, such as diazepam, for muscle relaxation. If patients do not close their eyes during the study, muscles of the eyes and eyelids will also show increased uptake.
Fig. 4A. 49-year-old woman with cancer of large intestine. Transverse positron emission tomography image shows normal appearance of parotid gland with moderate FDG uptake (short arrows) and low to moderate uptake (long arrows) at border and base of tongue and soft palate.
Fig. 4B. 49-year-old woman with cancer of large intestine. CT image corresponding to A provides comparison. Arrows indicate soft palate.
Fig. 5A. 62-year-old woman with melanoma. Transverse positron emission tomography image shows relatively strong FDG uptake in submandibular glands (arrows).
Fig. 5B. 62-year-old woman with melanoma. CT image of floor of mouth, corresponding to A, provides comparison.
Fig. 6A. 56-year-old man with liver cancer. Transverse positron emission tomography image shows FDG uptake at insertion site of genioglossus muscle (short arrows), which keeps tongue in position in supine patients. Muscular uptake in longus capitis muscle (long arrow) can mimic lymph node involvement in transverse PET image.
Fig. 6B. 56-year-old man with liver cancer. CT image corresponding to A provides comparison. Arrow indicates longus capitis muscle.
Fig. 7A. 36-year-old man with seminoma. Coronal positron emission tomography (PET) image shows FDG uptake in sternocleidomastoid (scm) and medial pterygoid (pm) muscles.
Fig. 7B. 36-year-old man with seminoma. Coronal PET image reveals FDG uptake in sternocleidomastoid (scm) and longus capitis muscle (lcm).
Fig. 7C. 36-year-old man with seminoma. Transverse PET image shows FDG uptake in longus capitis muscle (lcm), which can mimic uptake in epipharyngeal lymph node (Rouvière's node or Rosenmüller's cavity). Differentiation of this uptake from lymph node involvement can be difficult. Muscular uptake is usually not nodular and can be easily discriminated from lymph node involvement with proper image analysis. Asterisk indicates cerebellum.
Fig. 8. 76-year-old woman with pancreatic cancer. Coronal PET image shows laryngeal FDG uptake at vocal cords (arrows) because patient spoke during FDG uptake phase. In patients with laryngeal nerve palsy due to Pancoast's tumor or nerve damage after surgery, unilateral uptake (not shown) can be visible.

Treatment Effects

Dental problems are common in patients with head and neck cancer. If infectious disease of dental roots and the periodontal space are present, the teeth will generally be removed before radiation treatment is started. This surgery will cause an inflammatory reaction in the jaw, mucosal membranes, and underlying soft tissues. A strong FDG uptake can be visible for several weeks (Figs. 9 and 10A,10B). After chemotherapy, FDG uptake of the bone marrow may increase (Fig. 11). In patients with a tracheal stoma, FDG uptake can occur when inflammation is present at the borders (Fig. 12). Radiation therapy can cause pharyngitis and esophagitis, which can be visible as increased FDG uptake in the mucosal membrane (Fig. 13A,13B).
Fig. 9. 65-year-old woman with hypopharyngeal cancer. Transverse positron emission tomography image obtained 1 week after surgical removal of teeth in patient scheduled for radiation treatment shows strong bilateral FDG uptake in lower jaw. Dental extraction is often performed in patients with head and neck cancer before radiation treatment, and FDG uptake, which can mimic uptake in malignant lesion, continues to be visible for several weeks.
Fig. 10A. 63-year-old man with hypopharyngeal cancer. Transverse positron emission tomography image shows anterior part of jaw in patient whose teeth were removed 3 weeks before imaging.
Fig. 10B. 63-year-old man with hypopharyngeal cancer. CT image corresponding to A provides comparison.
Fig. 11. 62-year-old man who received chemotherapy for non-Hodgkin's lymphoma. Sagittal positron emission tomography image shows increased FDG uptake in bone marrow caused by rebound of marrow cells. Bone marrow uptake could be decreased if vertebral column (not shown) were in field of irradiation.
Fig. 12. 53-year-old man with tracheostoma after laryngectomy. Transverse positron emission tomography image shows increased FDG uptake at borders of tracheostoma. Such inflammation can mimic local recurrence.
Fig. 13A. 42-year-old man who received combined radiation and chemotherapy for hypopharyngeal carcinoma. Primary carcinoma and lymph node metastases were successfully treated. Sagittal positron emission tomography (PET) CT image shows increased FDG uptake in mucosal membrane and adjacent soft tissues of hypopharynx and esophagus 5 weeks after treatment. Mucositis is common inflammatory reaction of mucosal membrane of pharynx and esophagus soon after therapy.
Fig. 13B. 42-year-old man who received combined radiation and chemotherapy for hypopharyngeal carcinoma. Primary carcinoma and lymph node metastases were successfully treated. Sagittal PET image shows involvement of esophagus. Clinical information helped us to correctly interpret this finding as treatment effect.

Growth Pattern and Visibility of Benign Lesions

A lesion with a nodular growth pattern is more visible than a superficially spreading lesion—for example, in the mucous membrane. A lesion with increased FDG uptake in the salivary gland is often from a papillary cystadenoma lymphomatosum (Warthin's tumor) (Fig. 14). This benign lymphoepithelial proliferation is the second most common salivary gland tumor and is often seen in smokers [7] (Fig. 14). A benign lesion, such as sinusitis, can show variable intensity of FDG uptake. A nodular lesion can have very strong FDG uptake even when benign, whereas a malignant lesion with a superficially spreading growth pattern can show low FDG uptake. An example of a mucosal malignant melanoma located in a mucous membrane is shown in Figure 15. Although melanoma avidly takes up FDG, this growth pattern does not allow discrimination of this lesion from a benign inflammation such as sinusitis [8] (Fig. 15).
Fig. 14. 44-year-old man with bronchogenic carcinoma. Transverse positron emission tomography image reveals focal uptake in right parotid gland (arrow). This lesion was Warthin's tumor, a benign lymphoepithelial proliferation with nodular growth pattern.
Fig. 15. 72-year-old woman with mucosal malignant melanoma. Transverse positron emission tomography (PET) image shows moderate FDG uptake in maxillary sinus (arrows). PET was performed for N- and M- staging of metastasis [9]. Amount of FDG uptake alone cannot be used to discriminate between benign and malignant lesions. Melanoma cells avidly take up FDG, but because this lesion has superficially spreading growth pattern, uptake appears to be low.

Conclusion

Image quality in FDG PET and PET CT depends on both patient preparation and the technical quality of image acquisition. Metal parts, such as dental bridgework, should be removed, and patients should be instructed not to speak during the FDG uptake phase. Attenuation-corrected PET studies should be compared with the uncorrected emission scans to check for movement artifacts and artifacts due to dental metalwork. Lesions should be identified in coronal, transverse, and sagittal planes to avoid misinterpretation as muscular uptake. Clinical information is important to correctly identify changes resulting from treatment. Familiarity with normal imaging appearances helps in discriminating pathologic lesions from artifacts.

Footnote

Address correspondence to G. W. Goerres.

References

1.
McGuirt WF, Williams DW 3rd, Keyes JW Jr, et al. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography. Laryngoscope 1995; 105:373-375
2.
Farber LA, Benard F, Machtay M, et al. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography. Laryngoscope 1999; 109:970-975
3.
Keyes JW Jr, Watson NE Jr, Williams DW 3rd, Greven KM, McGuirt WF. FDG PET in head and neck cancer. AJR 1997; 169:1663-1669
4.
Sakamoto H, Nakai Y, Ohashi Y, et al. Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas. Acta Otolaryngol 1998; 538[suppl]:254-260
5.
Kinahan PE, Townsend DW, Beyer T, Sashin D. Attenuation correction for a combined 3D PET/CT scanner. Med Phys 1998; 25:2046-2053
6.
Goerres GW, Hany TF, Kamel E, von Schulthess GK, Buck A. Head and neck imaging with PET and PET/CT: artefacts from dental metallic implants. Eur J Nucl Med Mol Imaging 2002; 29:367-370
7.
Okamura T, Kawabe J, Koyama K, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of parotid mass lesions. Acta Otolaryngol 1998; 538[suppl]:209-213
8.
Goerres GW, Stoeckli SJ, von Schulthess GK, Steinert HC. FDG PET for mucosal malignant melanoma of the head and neck. Laryngoscope 2002; 112, 381-385
9.
Sobin LH, Wittekind C, eds. TNM classification of malignant tumours, 5th ed. Baltimore: Wiley-Liss, 1997

Information & Authors

Information

Published In

American Journal of Roentgenology
Pages: 1337 - 1343
PubMed: 12388526

History

Submitted: January 9, 2002
Accepted: April 10, 2002
First published: November 23, 2012

Authors

Affiliations

Gerhard W. Goerres
All authors: Division of Nuclear Medicine, University Hospital Zurich, Raemistr. 100, CH-8091 Zurich, Switzerland.
Gustav K. von Schulthess
All authors: Division of Nuclear Medicine, University Hospital Zurich, Raemistr. 100, CH-8091 Zurich, Switzerland.
Thomas F. Hany
All authors: Division of Nuclear Medicine, University Hospital Zurich, Raemistr. 100, CH-8091 Zurich, Switzerland.

Metrics & Citations

Metrics

Citations

Export Citations

To download the citation to this article, select your reference manager software.

Articles citing this article

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media